Maria-Athina Altzerinakou

3PUBLICATIONS
29CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jun 25, 2026
Biomarker analysis from patients with metastatic PDAC treated with TGFβ antibody, NIS793, plus abraxane+gemcitabine vs. abraxane+gemcitabine alone in a phase II, open label, randomized study.

|Feb 09, 2021
Change-point joint model for identification of plateau of activity in early phase trials.

Maria-Athina Altzerinakou, Xavier Paoletti

|Apr 05, 2019
An adaptive design for the identification of the optimal dose using joint modeling of continuous repeated biomarker measurements and time-to-toxicity in phase I/II clinical trials in oncology.

Maria-Athina Altzerinakou, Xavier Paoletti

Pageof 1

Frequent Collaborators

1 joint publications

Marc Pelletier

1 joint publications

Jie Yang

1 joint publications

Mukta Joshi

1 joint publications

Angelo Grauel